查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
BPH 治疗市场：按产品类型、按应用、按国家、按地区 - 行业分析、市场规模、市场份额、2023-2030 年预测
市场调查报告书
商品编码
1290832

BPH 治疗市场：按产品类型、按应用、按国家、按地区 - 行业分析、市场规模、市场份额、2023-2030 年预测

Benign Prostatic Hyperplasia Treatment Market with COVID-19 Impact Analysis, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 354 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年良性前列腺增生治疗市场规模将达到110.54亿美元，2023年至2030年復合年增长率为5.9%

良性前列腺增生治疗市场 - 市场动态

BPH 治疗市场的增长主要是由 BPH 患病率上升推动的。

世界人口迅速承受良性前列腺增生等与年龄相关的疾病的负担，已成为全球健康的优先事项。BPH 是老年男性常见的泌尿系统疾病。根据尸检评估，良性前列腺增生的年龄特定患病率在 40 岁时为 8%，在 6 岁时为 50%，在 9 岁时为 80%。主要由于人口增长和老龄化，前列腺增生症的负担在世界范围内不断增加。总体而言，BPH 治疗市场的增长主要是由 BPH 患病率上升以及与 BPH 相关的泌尿系统疾病增加推动的。

良性前列腺增生治疗市场 - 主要见解

  • 由于可持续增长意识的增强，预计良性前列腺增生治疗行业将大幅增长
  • 按产品类型划分，药物治疗预计将在 2022 年占据最大的市场份额。
  • 从用途来看，家庭医疗保健是2022年的主要类型。
  • 按地区划分，北美将在 2022 年销量领先。

良性前列腺增生治疗市场细分分析：

全球良性前列腺增生治疗市场根据产品类型、应用、技术和地区进行细分。

根据产品类型，市场分为三类：药物治疗、微创手术、激光治疗等。药物治疗在缓解症状和预防 BPH 进展的市场上占据主导地位。

市场按应用分为四类：医院、门诊手术中心、专科诊所、家庭护理等。家庭医疗保健在市场中占据主导地位，预计在预测期内将保持其主导地位。此外，患者应在术后数週内继续服用处方药。因此，市场更关注家庭护理而不是医院护理。

良性前列腺增生治疗市场 - 地理洞察

从地理上看，该市场遍布北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些地区根据引入业务的国家进一步划分。由于北美老年人口不断增长，公众对可用治疗方案的认识不断提高，预计北美将主导良性前列腺增生治疗市场的增长。根据美国社区调查（ACS）数据用户组的数据，65岁及以上的美国人数量将从2018年的5200万增加近一倍，到2060年达到9500万，其中65岁及以上年龄组占总人口的百分比。预计将从 16% 上升至 23%。良性前列腺增生治疗市场受到不同市场驱动因素和不同地区最终用户行业的影响。良性前列腺增生治疗市场的公司正在开发专门的解决方案，以满足欧洲、亚太地区、拉丁美洲、中东和非洲等地区客户的特定需求。

良性前列腺增生治疗市场 - 竞争格局：

新产品发布、分销网络开发、研发支出和併购是公司用来扩大影响力和增加市场份额的一些关键技术。每家公司都提供不同的治疗方案和技术，治疗选择取决于患者的病情、偏好和医疗保健提供者的专业知识等因素。咨询泌尿科医生或医疗保健专业人员非常重要，他们可以评估您的具体情况并推荐最合适的治疗方法。例如，Boston Scientific最近宣布从 Celsion 公司购买治疗症状性良性前列腺增生的技术，这一消息是在该公司 6 月 13 日的年会上宣布的。随后，股东们已经批准了这项收购。

近期动向

2022 年，设计和提供创新医疗技术解决方案的全球技术领导者OLYMPUS宣布在加拿大首次采用微创 iTind 方法 Did 商业化治疗良性前列腺增生 (BPH)。

研究的主要特点

  • 这份关于良性前列腺增生治疗市场的研究报告提供了以 2022 年为基准年的市场规模、复合年增长率、估计和预测（2023-2030 年）。
  • 该研究报告为客户提供了对良性前列腺增生治疗市场最新发展的深入了解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并阐述了良性前列腺增生治疗市场有吸引力的投资主张矩阵。
  • 总体报告确定了良性前列腺增生治疗市场的新投资机会、现有企业面临的挑战以及可持续发展的增长动力
  • 研究范围内详细讨论了 COVID-19 对 BPH 治疗市场规模、预测、复合年增长率和市场动态的影响。它还涵盖了对新冠疫情后良性前列腺增生治疗市场的深入见解。
  • 为了向本报告的用户提供 BPH 市场的全面了解，还包括 BPH 市场的竞争格局和关键创新者分析。
  • 该研究涵盖了基于市场规模、增长率和吸引力对所有行业领域进行基准测试的增长前景映射分析。
  • 该报告提供了主要市场进入者的详细公司概况，帮助用户了解在 BPH 市场运营的公司的财务信息和战略举措。
  • 此外，报告还揭示了全球和区域市场主要进入者的重大收购和兼併、联盟和合资企业、新产品推出、研发和区域扩张。
  • 全球良性前列腺增生治疗市场报告主要面向该行业的各个利益相关者，如供应商、投资者、新进入者、分销商和财务分析师。

目录

第一章良性前列腺增生治疗市场概述

  • 调查范围

第二章执行摘要

  • 市场细分
  • 竞争考虑

第三章 BPH 治疗的主要市场趋势

  • 良性前列腺增生治疗市场驱动因素
  • 良性前列腺增生治疗市场的製约因素
  • 良性前列腺增生治疗市场机会
  • 良性前列腺增生治疗市场的未来趋势

第四章前列腺增生症治疗行业概况

  • PEST分析
  • 波特五力分析
  • 绘製增长前景
  • 监管框架分析

第五章 BPH 治疗市场：COVID-19 的影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析

第六章良性前列腺增生治疗市场格局

  • 2022 年良性前列腺增生治疗市场份额分析
  • 主要製造商的细分数据
    • 现有公司分析
    • 启动分析

7. BPH 治疗市场 - 按产品类型

  • 概述
    • 按产品类型划分的细分市场份额分析
    • 药物治疗
    • 微创手术
    • 激光治疗
    • 其他

8.良性前列腺增生治疗市场——按应用分类

  • 概述
    • 按应用划分的细分市场份额分析
    • 医院
    • 门诊手术中心
    • 专科诊所
    • 家庭保健
    • 其他

9.良性前列腺增生治疗市场——按地区

  • 介绍
  • 北美
    • 概述
    • 北美 BPH 治疗的领先製造商
    • 美国
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲良性前列腺增生治疗的领先製造商
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 其他
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区良性前列腺增生治疗的领先製造商
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印度尼西亚
    • 菲律宾
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲 BPH 治疗的领先製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他
  • 中东和非洲
    • 概述
    • 中东和非洲前列腺增生症治疗的领先製造商
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他

10.主要供应商分析-良性前列腺增生治疗行业

  • 比赛仪表板
  • 公司简介
    • Carrier
    • Daikin Industries, Ltd
    • NIBE GroupViessmann Group
    • Glen Dimplex
    • BDR Thermea Group
    • Midea Group
    • Hitachi, Ltd.
    • Ingersoll Rand Plc.
    • STIEBEL ELTRON GmbH &Co. KG
    • Vaillant Group
    • Robert Bosch GmbH
    • The Danfoss Group

第十一章 分析师的全面看法

Product Code: ANV1307

REPORT HIGHLIGHT

Benign Prostatic Hyperplasia Treatment Market size was valued at USD 11,005.4 million in 2022, expanding at a CAGR of 5.9% from 2023 to 2030.

Benign prostatic hyperplasia, a noncancerous enlargement of the prostate gland, is the most common benign tumor found in men. Many treatments are available for enlarged prostate. These include medicines, surgery, and procedures that involve smaller, fewer, or no cuts. Furthermore, New BPH treatments are less invasive and damaging to healthy tissue than surgery. In general, most of these treatments are outpatient procedures, which means consumers can go home the same day as the procedure. They're also cheaper, have fewer side effects and allow for a faster recovery.

Benign Prostatic Hyperplasia Treatment Market- Market Dynamics

The growth of the benign prostatic hyperplasia therapeutics market is majorly driven due to the rise in the prevalence of benign prostatic hyperplasia.

The global population urging the burden of age-associated diseases, such as benign prostatic hyperplasia, has become a global health priority. Benign prostatic hyperplasia is a common urological disease among older men. The age-specific prevalence of benign prostatic hyperplasia has been estimated from autopsy evaluations to be 8% in the fourth decade of life, 50% in the sixth decade of life, and 80% in the ninth decade of life. The burden of benign prostatic hyperplasia is rising throughout the world, primarily due to population growth and aging. Overall, the growth of the benign prostatic hyperplasia therapeutics market is majorly driven due to the rise in the prevalence of benign prostatic hyperplasia as well as the rise in urological illnesses linked with benign prostatic hyperplasia.

Benign Prostatic Hyperplasia Treatment Market- Key Insights

  • As per the analysis shared by our research analyst, the global Benign Prostatic Hyperplasia Treatment market is estimated to grow annually at a CAGR of around 5.5.% over the forecast period (2023-2030)
  • The Benign Prostatic Hyperplasia Treatment industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Product type segmentation, Drug treatment was predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Home healthcare was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Benign Prostatic Hyperplasia Treatment Market- Segmentation Analysis:

The Global Benign Prostatic Hyperplasia Treatment Market is segmented on the basis of Product Type, Application, Technology, and Region.

The market is divided into three categories based on product type: Drug treatment, Minimally Invasive Surgeries, laser therapy, and others. Drug treatment dominates the market due to providing symptom relief and facilitating prevent the progression of BPH.

The market is divided into four categories based on application: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, home healthcare, and Others. Home healthcare dominates the market and is likely to maintain its dominance during the forecast period. Patients should also continue taking their prescriptions for a few weeks after surgery. As a result, in his market, the emphasis is biased toward home healthcare rather than hospital care.

Benign Prostatic Hyperplasia Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Benign Prostatic Hyperplasia Treatment market, due to the increasing geriatric population, and rising awareness among the general public about the available treatment options. According to American Community Survey (ACS) Data Users Group, the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060, and the 65-and-older age group's share of the total population will rise from 16 percent to 23 percent. The Benign Prostatic Hyperplasia Treatment market is influenced by different market drivers and end-user industries across different regions. Companies in the Benign Prostatic Hyperplasia Treatment market develop specialized solutions to meet the specific needs of customers in each region like Europe, Asia pacific, Latin America, the Middle East & Africa, etc.

Benign Prostatic Hyperplasia Treatment Market- Competitive Landscape:

Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. Each of these companies provides different treatment options and technologies, and the choice of treatment depends on factors such as the patient's condition, preferences, and the expertise of the healthcare provider. It's crucial to consult with a urologist or healthcare professional who can assess specific cases and recommend the most appropriate treatment approach. For example, Boston Scientific Corporation recently announced that it has purchased technology for treating symptomatic benign prostatic hyperplasia from Celsion Corporation, following approval of the acquisition by Celsion stockholders at the company's annual meeting on June 13.

Recent Developments:

In 2022, Olympus, a global technology leader in designing and delivering innovative medical technology solutions, announced nowadays the first commercial treatment of Benign Prostatic Hyperplasia (BPH) in Canada using the minimally invasive iTind procedure.

Key features of the study:

  • This proposed research study on Benign Prostatic Hyperplasia Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Benign Prostatic Hyperplasia Treatment market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Benign Prostatic Hyperplasia Treatment market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Benign Prostatic Hyperplasia Treatment market
  • Impact of COVID-19 on Benign Prostatic Hyperplasia Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Benign Prostatic Hyperplasia Treatment market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Benign Prostatic Hyperplasia Treatment market, we have also included competitive landscape and key innovator analysis for the Benign Prostatic Hyperplasia Treatment market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Benign Prostatic Hyperplasia Treatment market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Benign Prostatic Hyperplasia Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET KEY PLAYERS

  • Boston Scientific Corporation
  • Teleflex Incorporated
  • Endo International plc
  • Urologix, LLC
  • LISA Laser
  • Olympus Corporation
  • Other

GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY PRODUCT TYPE

  • Drug Treatment
  • Alpha-blockers
  • 5-Alpha-reductase Inhibitor (5-ARIs)
  • Phosphodiesterase-5 Enzyme Inhibitor
  • Others
  • Minimally Invasive Surgeries
  • Transurethral Resection of the Prostate (TURP)
  • Transurethral Incision of the Prostate (TUIP)
  • Robotic Surgeries
  • Transurethral Microwave Thermotherapy (TUMT)
  • Prostatic Urethral Lift
  • Others
  • Laser Therapy
  • Others

GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY APPLICATION

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Home healthcare
  • Others

GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Benign Prostatic Hyperplasia Treatment Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Benign Prostatic Hyperplasia Treatment Market Snippet by Product Type
    • 2.1.2. Benign Prostatic Hyperplasia Treatment Market Snippet by Application
    • 2.1.3. Benign Prostatic Hyperplasia Treatment Market Snippet by Country
    • 2.1.4. Benign Prostatic Hyperplasia Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Benign Prostatic Hyperplasia Treatment Key Market Trends

  • 3.1. Benign Prostatic Hyperplasia Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Benign Prostatic Hyperplasia Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Benign Prostatic Hyperplasia Treatment Market Opportunities
  • 3.4. Benign Prostatic Hyperplasia Treatment Market Future Trends

4. Benign Prostatic Hyperplasia Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Benign Prostatic Hyperplasia Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Benign Prostatic Hyperplasia Treatment Market Landscape

  • 6.1. Benign Prostatic Hyperplasia Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Benign Prostatic Hyperplasia Treatment Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Drug Treatment
    • 7.1.3. Minimally Invasive Surgeries
    • 7.1.4. Laser Therapy
    • 7.1.5. Others

8. Benign Prostatic Hyperplasia Treatment Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Ambulatory Surgical Centers
    • 8.1.4. Specialty Clinics
    • 8.1.5. Home healthcare
    • 8.1.6. Others

9. Benign Prostatic Hyperplasia Treatment Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Benign Prostatic Hyperplasia Treatment Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Carrier
    • 10.2.2. Daikin Industries, Ltd
    • 10.2.3. NIBE GroupViessmann Group
    • 10.2.4. Glen Dimplex
    • 10.2.5. BDR Thermea Group
    • 10.2.6. Midea Group
    • 10.2.7. Hitachi, Ltd.
    • 10.2.8. Ingersoll Rand Plc.
    • 10.2.9. STIEBEL ELTRON GmbH & Co. KG
    • 10.2.10. Vaillant Group
    • 10.2.11. Robert Bosch GmbH
    • 10.2.12. The Danfoss Group

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Benign Prostatic Hyperplasia Treatment Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Benign Prostatic Hyperplasia Treatment Market, by Product Type 2018-2030 (USD Million)
  • TABLE Benign Prostatic Hyperplasia Treatment Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Benign Prostatic Hyperplasia Treatment Market, by Application 2018-2030 (USD Million)
  • TABLE Benign Prostatic Hyperplasia Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Benign Prostatic Hyperplasia Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)